| Role |
Name |
Disclosure |
Details |
| Author | Joel Schlessinger, MD, Consulting Staff, Dermatology, Skin Specialists, PC | Nothing to disclose | Details | | Coauthor | Robert M McNamara, MD, FAAEM, Chair and Professor, Department of Emergency Medicine, Temple University School of Medicine | Nothing to disclose | Details | | Medical Editor | Neil Shear, MD, Professor and Chief of Dermatology, Professor of Medicine, Pediatrics and Pharmacology, University of Toronto Faculty of Medicine; Head of Dermatology, Sunnybrook Women's College Health Sciences Center and Women's College Hospital, Canada | Nothing to disclose | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Paul Krusinski, MD, Director of Dermatology, Professor, Department of Internal Medicine, Fletcher Allen Health Care, University of Vermont | Nothing to disclose | Details | | CME Editor | Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Paul Krusinski, Managing Editor |
The contributor discloses no conflict of interest. |
|